Kausik Ray, MD

Professor of Public Heath, Department of Public Health and Primary Care, Imperial College London & Honorary Consultant Cardiologist, Imperial College NHS Trust Prof Ray is currently President of the European Atherosclerosis Society, Chair of the World Heart Federation Cholesterol Roadmap 2021-2022, Chair for Global Council for Heart Health. National Lead for CVD NIHR Academic research Collaboration, Clinical Director for Research HDR UK Digital Innovation Hub DISCOVER Now.

He received his medical education (MB ChB, 1991) at the University of Birmingham Medical School, his MD (2004) at the University of Sheffield, a postdoctoral fellowship at Harvard Medical School and finally an MPhil in epidemiology (2007) from the University of Cambridge. His research involves lipids, diabetes and population health serving as global lead for trials and registries. He has >120,000 citations and since 2018 has been recognised annually by Clarivate Analytics as among the top 0.1% of authors in global medicine.

He lead the international development program for Inclisiran, the first siRNA-based therapy for cholesterol-lowering approved globally, in addition to playing a key role in the development program of Bempedoic Acid and PCSK9 monoclonal antibodies. He initiated the Familial Hypercholesterolaemia Studies Collaboration (FHSC), the only global registry of FH, as well as multi-national European registries such as Da Vinci, Heymans and Santorini, all of which are helping to shape global health policy.


Baim- and Baim-affiliated faculty members disclose the conflicts of interest for the Baim Institute which can be viewed here.